CD38 and rheumatoid arthritis: The expression of plasmablast surface markers, CD38, CD27, CD138/SDC1, and SLAMF7 were upregulated in early RA synovial tissue biopsies compared to healthy synovium and down-regulated after tDMARD treatment (Fig 4C).